Status: Private

 

Kailera is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity. Their pipeline consists of clinical stage programs with injectable peptides, oral peptides, and an oral small molecule.

 

To learn more, please visit: www.kailera.com